Quantcast

Latest Hurler Syndrome Stories

2010-09-23 08:00:00

NOVATO, Calif., Sept. 23 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today the appointment of William D. Young and Kenneth M. Bate to its Board of Directors. "We are extremely pleased to welcome William Young and Kenneth Bate to our Board of Directors.

2010-09-14 08:00:00

NOVATO, Calif., Sept. 14 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.

2010-09-09 08:00:00

NOVATO, Calif., Sept. 9 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.

2010-09-08 08:00:00

NOVATO, Calif., Sept. 8 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will present a company update at the Robert W.

2010-09-07 08:00:00

NOVATO, Calif., Sept. 7 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.

2010-09-01 08:00:00

NOVATO, Calif., Sept. 1 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.

2010-08-30 08:00:00

NOVATO, Calif., Aug. 30 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that it has received orphan drug designation from the U.S.

2010-08-17 15:27:00

NOVATO, Calif., Aug. 17 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that it has acquired ZyStor Therapeutics, Inc.

2010-08-17 08:00:00

NOVATO, Calif., Aug. 17 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc.

2010-08-02 15:01:00

NOVATO, Calif., Aug. 2 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today an update in the Phase 2 clinical study of PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase) for the treatment of phenylketonuria (PKU).


Word of the Day
whirret
  • To give a box on the ear to.
The word 'whirret' may be onomatopoeic.